Name
Neurotrophic Keratitis: Past, Present, and Future Treatments
Date & Time
Friday, February 14, 2025, 9:45 AM - 10:35 AM
Speakers
Description
"This one-hour course will review the risk factors and pathophysiology of neurotrophic keratitis. The presenters will review diagnostic techniques, as well as discuss the available treatment options, including autologous serum, amniotic membranes, and the only FDA approved topical biologic, cenegermin-bkbj (Oxervate). Future and pipeline treatments will also be discussed. Case presentations and live polling will be used to enhance the learning and discussion."
Accreditation
1 hour of COPE
Intended Audience
ODs and Associate ODs